Chronic Cardiovascular Disease Stats Case

Executive Summary:

Chronic Cardiovascular disease including heart attack and stroke remains the nation's No. 1 killer of men and women, causing more than 36% of all deaths1. It is estimated that 87 percent of people who die of coronary heart disease are 60 and older. Management of chronic diseases such as diabetes, congestive heart failure has gradually shifted from acute hospital care remote Patient Monitoring and it's allowing many people with chronic disease to remain at home without direct physical care. Medical management of chronic cardiovascular disease has become increasingly reliant upon the use of implanted electronic devices (ICD/Pacemaker) for management. Remote Cardiac Monitoring (RCM) offers to the monitoring and management of patient Heart conditions. The monitoring occurs within a remote environment (remote from the Care provider) such as the patient's home.

Our Remote Cardiac Monitor Service (iHeartCare) a service product concept for remote cardiac monitoring service, connecting cardiac device patients to their clinic from home or away. It offers a variety of technologies to help secure the valuable details of a patient's heart rhythms, enabling diagnosis and timely patient management. The use of RCM to remotely assess patients' Cardiac pattern will help to reduce the frequency of some clinic visits. This service allows for an early detection of changes in conditions. Additionally, remote monitoring provides clinicians with insight into whether the patient is complying with the program.

Market Projections:

Remote Cardiac monitoring technologies will play a major role in U.S. healthcare, a recent report projected that the market is set to grow 26 percent overall, from $6 billion this year to more than $18 billion by 20142. Such predictions are reinforced by estimates that globally, 2.2 million patients use remote monitoring services. While this technology could be developed to be the global market, we continue to choose North America to assess market sizes due to its well-documented occurrence of chronic cardiovascular disease prevalence. Additionally, many different sub-sectors of the industry will be drawn upon in order to make this program successful such as government oversight (FDA) and approval for reimbursement, a well-educated physician base, a long term medical device manufacturing plan, IT industry and a patient base that has the financial means either independently or through insurance coverage.

In 2011, about 80 million Americans had 1 or more types of cardiovascular disease. Of these, about 38 million are estimated to be 60 years of age or older. Therefore to estimate if we consider about 12 % of that population representing a realistic sub-group that would willing to switch over to remote cardiac Monitoring Services4, we get a patient base of 9.6 million people. In addition, it is important